Chicago-based health-tech pioneer delivers up to 99.99% pathogen reduction with Far-UVC 222nm lights for 24/7 indoor-space protection from virus, mold, bacteria
LAS VEGAS , NV, UNITED STATES, January 7, 2026 /EINPresswire.com/ — While flu hospitalizations nationwide double weekly and a new viral variant drives record school outbreaks and absenteeism, Beacon makes a timely debut of its breakthrough continuous disinfection technology at CES 2026, delivering the autonomous infection-control solution healthcare facilities, schools, and senior living communities so urgently need right now.
Unlike traditional cleaning that stops working the moment it’s finished, or air purifiers that address only airborne threats while surfaces remain recontamination threats, Beacon’s Far-UVC 222nm lights eliminates up to 99.99% of bacteria, viruses, and mold on both air and surfaces—continuously and safely, in occupied spaces, 24/7.
“We’ve figured out how to have clean water. Safer buildings. AI is rapidly transforming healthcare,” said Brian Clark, CEO and co-founder of Beacon. “But indoor air—where we spend an average of 90% of our lives taking 20,000 breaths per day—remains dangerously pathogen-laden. Beacon changes this.”
Clinical Proof, Real-World Impact
Beacon’s efficacy isn’t just lab tested, it’s been validated in the field. Pilot studies show:
-97.4% pathogen reduction in a Chicago school classroom
-99.5% improvement in a New York medical clinic environment
-63% pathogen reduction in occupied hospital patient room
“Traditional infection control creates recontamination gaps,” said Howard Fullman, Chief Medical Officer, Beacon “Pathogens get reintroduced with every new person in a room, with every breath. Beacon lights close that gap with continuous antimicrobial activity for rapid and sustained protection throughout the workday, with zero workflow disruption.”
Why Now Matters: The Convergence of Crisis and Innovation
The urgency is undeniable:
-Flu hospitalizations surged from 9,944 to 19,053 in one week (late December 2025)
-School absenteeism remains at 28–31% post-pandemic, costing districts millions in lost attendance funding
-Chronic absenteeism linked to 20% of the achievement gap; higher ventilation classrooms show 14–15% higher test scores
-Healthcare-associated infections cost the U.S. $28–45 billion annually
Beacon addresses all of these pain points with a plug-and-play, EPA/FCC compliant device that requires no behavior change, no chemicals, no filter replacements—and delivers measurable results within minutes.
Strong Market Momentum: 130% Monthly Growth Post-Launch
Since launching Beacon V2 in October 2025, the company has achieved 130% average month-over-month sales growth, 231% unit-sales increase, 139% revenue growth, and adoption across healthcare, education, dental, and residential sectors.
“Healthcare facilities, classrooms and workplaces don’t need another cleaning protocol—they need continuous, autonomous protection that works around the clock, while people are present,” says co-founder and Head of Public Health Research Andrea Clark. “Beacon is changing the standard of disinfection to continuous, without requiring you to change how you operate.”
Join Us at CES 2026
Booth #54123 | AgeTech Collaborative™ from AARP
January 6–9, 2026 | Las Vegas Convention Center
Beacon will showcase live demonstrations, share clinical data, and discuss pilot opportunities for hospitals, schools, senior living facilities, and other commercial and workplace environments.
About Beacon
Beacon is the leader in Far-UVC 222nm continuous disinfection for occupied spaces. Using patented Far-UVC 222nm light technology, Beacon’s products safely neutralizes up to 99.99% of airborne and surface pathogens—including viruses, bacteria, and mold—in real-time. Unlike traditional disinfection methods that require evacuation or provide only temporary disinfection, Beacon operates continuously in homes, healthcare facilities, schools, offices, and other critical environments without disrupting daily operations for continuous disinfection of environmental pathogens. With intelligent sensors and proprietary algorithms that maintain stringent safety thresholds, Beacon delivers measurable pathogen reduction while reducing operational costs and illness burden. Learn more at www.beaconlight.co
Contact: Heidi Darling heidi@beaconlight.co
Heidi Darling
Beacon
+1 415-302-4777
email us here
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
